Document is current
Any future updates will be listed below
-
Authors
Novak, Richard https://orcid.org/0000-0003-0485-4284
Lin, Tiffany
Kaushal, Shruti
Sperry, Megan
Vigneault, Frederic https://orcid.org/0000-0002-9163-1558
Gardner, Erica
Loomba, Sahil
Shcherbina, Kostyantyn
Keshari, Vishal
Dinis, Alexandre https://orcid.org/0000-0002-6813-6380
Vasan, Anish https://orcid.org/0000-0001-7714-262X
Chandrasekhar, Vasanth
Takeda, Takako https://orcid.org/0000-0001-9140-1018
Nihalani, Rahul
Umur, Sevgi
Turner, Jerrold R.
Levin, Michael https://orcid.org/0000-0001-7292-8084
Ingber, Donald E. https://orcid.org/0000-0002-4319-6520
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 16 June 2025
First Online: 1 July 2025
Competing interests
: R.N., F.V., E.G., S.U., R.Ni., M.L. and D.E.I. hold equity in Unravel Biosciences, Inc.; R.N., F.V., and D.E.I. are members of its board of directors; M.L. and D.E.I. are members of its scientific advisory board; and R.N., F.V., E.G., S.U. and R.Ni. are current or past employees of the company.
